Check Claims Before You Publish

Author snapshot — W. Paul Duprex

Active, highly‑cited virologist with strong track record in measles/paramyxovirus biology and rapid pivot to SARS‑CoV‑2 research; metrics vary by source (h‑index 41 vs 57; >4,500–11,900 citations) — see representative works below.

• Recurrent deletions in SARS‑CoV‑2 spike (Science, 2021) — antigenic evolution/NTD deletions and immune escape (robust genomic + functional evidence).
• Predominant infection of CD150+ lymphocytes (PLoS Pathogens, 2007) — foundational mechanistic work on measles tropism in macaques.

Key quantitative sources: OpenAlex author profile (works_count=197; cited_by_count=11,913; h_index=57) and the provided author metrics (h_index=41; citations=4,534; 83 papers) — differences reflect database coverage and name disambiguation.

Quick links:

Open full BGPT author query

Author Review: W. Paul Duprex — visual, evidence‑based critique

Figure 1 — Publications per year (OpenAlex counts_by_year)

Interpretation: OpenAlex reports sustained productivity with spikes in 2007, 2011–2012, 2014, and a major rise in 2020–2021 coincident with the COVID‑19 pandemic and collaborative, high‑visibility reviews and multi‑author studies Nature 2020 animal-models review

Figure 2 — Cumulative citations (two available snapshots)

Interpretation: Citation totals differ substantially across sources (4,534 vs ~11,900) due to database coverage (Scopus/Google Scholar/OpenAlex differ in including conference papers, preprints, consortium papers, and name disambiguation). Use multiple indices when assessing impact; OpenAlex shows broader coverage here OpenAlex author snapshot

Figure 3 — Representative high‑impact papers (selected by citation and relevance)

Notes: These papers exemplify two threads: (1) fundamental paramyxovirus/measles biology (mechanistic animal and cell models) and (2) rapid translational/epidemiologic work during emergent outbreaks (SARS‑CoV‑2 surveillance & antigenic mapping). Both types raise different expectations for experimental control and inference strength.

Evidence synthesis — strengths

• Track record of mechanistic virology: multiple experimental studies on measles, mumps, canine/rinderpest, paramyxovirus neurovirulence and tropism using in vivo macaque or ferret models, ex vivo organotypic slices, recombinant viruses, and functional molecular virology approaches — consistent, deep domain expertise across decades PLoS Pathogens 2007 measles tropism
• Combination of genomic surveillance and functional follow-up: Science 2021 RDR study paired large GISAID sequence analysis (~146,795 sequences) with phylogenetics and targeted antigenicity assays, an integrative approach linking sequence patterns to functional immune escape—high methodological breadth and relevance to public health surveillance Science 2021 RDR deletions paper
• Collaborative, high‑visibility contributions: coauthorship on multi‑group consensus works (animal models for COVID‑19, paramyxovirus taxonomy, ICTV taxonomy updates), indicating community leadership and interdisciplinary reach ICTV Paramyxoviridae profile

Evidence synthesis — weaknesses, blindspots & biases

• Database metric variability / name disambiguation: h‑index and citation totals vary (BGPT input: h=41, citations=4,534, papers=83; OpenAlex: h=57, citations≈11,900, works=197). This signals either (a) different database coverage (preprints, conference papers, consortium papers), (b) author name mapping differences, or (c) inclusion of group/consortium contributions — caution when treating a single metric as definitive OpenAlex metrics discrepancy
• Collaborative papers vs individual contribution: many high‑impact items are large multi‑author studies and reviews (e.g., 'Animal models for COVID‑19'), so citation credit does not equate to singular intellectual ownership; evaluate specific papers for first/last‑author roles if assigning leadership credit.
• Sampling & functional assay limitations in some works: the Science 2021 RDR study itself acknowledges geographic GISAID sampling bias and limited monoclonal/sera panels — i.e., strong for detecting recurrent deletions, weaker for extrapolating global antigenic fitness without ongoing surveillance Science 2021 limitations
• Potential conflicts and funding transparency: no declared competing interests for the Science 2021 RDR study, but funder lists are large and diverse; always check original COI statements per paper for financial‑incentive bias (no evidence of COI influence here) Science 2021 COI and funding

Overall assessment (evidence‑weighted)

W. Paul Duprex is an established, domain‑expert virologist with sustained experimental contributions to paramyxoviruses (measles, mumps, canine distemper) and meaningful involvement in pandemic‑era SARS‑CoV‑2 research. Strengths lie in mechanistic animal models, virology techniques, and the ability to contribute to large, interdisciplinary consortia. The principal caveats are (1) metric variability across databases and (2) the distinction between leadership vs collaborative coauthorship when interpreting citation-based impact.

What would change this conclusion?

• Discovery of retracted or irreproducible key papers would lower confidence (no such patterns found in the reviewed records).
• Author-level evidence of undisclosed COIs across multiple works would reduce trust (no signals found in cited papers' COI statements for the representative works).
• Detailed breakdown showing most citations arise only from consortium authorship with negligible scientific input would alter assessment — recommend checking authorship position and contribution statements on high‑impact outputs.

Actionable recommendations for users evaluating Duprex's work

1. When assessing a specific claim, inspect the original paper's Methods, authorship roles, and raw data links (GenBank/GISAID accessions provided in many papers).
2. Use multiple bibliometric sources (OpenAlex, Scopus, Google Scholar) to triangulate impact and check for name disambiguation.
3. For translational claims (e.g., antigenic escape), prioritize studies with large functional antibody panels and in vivo correlates; interpret single‑mAb neutralization losses cautiously.

Representative citations (used above)

• Science 2021 RDR deletions
• PLoS Pathogens 2007 measles tropism
• Nature 2020 animal models review
• OpenAlex author metrics

If you want a deeper, automated analysis (author disambiguation across databases, per-paper authorship-role parsing, or extraction of Methods/COI details across Duprex's corpus), click to run an AI scientist agent.